Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer (DEBIRITUX)

This study has been terminated.
(Terminated due to poor subject enrolment)
Sponsor:
Collaborator:
Biocompatibles UK Ltd
Information provided by (Responsible Party):
Dirk Arnold, Martin-Luther-Universität Halle-Wittenberg
ClinicalTrials.gov Identifier:
NCT01060423
First received: January 27, 2010
Last updated: June 25, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)